Nxera Pharma Co (FRA:JSS) Other Current Payables: €0.0 Mil (As of Mar. 2026)


FRA:JSS Nxera Pharma Co Ltd FRA:JSS
72 GF Score
Price €5.10
GF Value €6.94
! 7 Warning Signs
View Full Analysis

What is Nxera Pharma Co Other Current Payables?

Nxera Pharma Co FRA:JSS 72 Other Current Payables is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:JSS with a GF Score™ of 72/100 and a GF Value™ of €6.94. The stock has 7 warning signs investors should review.

Nxera Pharma Co's Other Current Payables for the quarter that ended in Mar. 2026 was €0.0 Mil.

Nxera Pharma Co Other Current Payables Related Terms

Nxera Pharma Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co Other Current Payables Chart

Nxera Pharma Co Annual Data
Trend Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 0.00

Nxera Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:JSS
72GF Score
Nxera Pharma Co Ltd FRA:JSS
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nxera Pharma Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €0.0 Mil mean?
Nxera Pharma Co (FRA:JSS) has a Other Current Payables of €0.0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Nxera Pharma Co and its competitors.
Is Nxera Pharma Co's Other Current Payables too high?
Nxera Pharma Co's current Other Current Payables is €0.0 Mil. Overall, Nxera Pharma Co has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Nxera Pharma Co's Other Current Payables compare to VRTX and REGN?
Nxera Pharma Co's Other Current Payables of €0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Nxera Pharma Co and its competitors. Nxera Pharma Co's current Other Current Payables is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nxera Pharma Co stock overvalued right now?
Nxera Pharma Co (FRA:JSS) has a current Other Current Payables of €0.0 Mil. The stock's GF Value™ is €6.94, compared to a current price of €5.10 — trading 26.5% below its estimated fair value. The current Other Current Payables is €0.0 Mil. Nxera Pharma Co's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Nxera Pharma Co (FRA:JSS), the current Other Current Payables is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (FRA:JSS) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of €5.10 is trading 26.5% below its estimated GF Value™ of €6.94.

Key valuation signals for FRA:JSS:

  • Other Current Payables: €0.0 Mil
  • GF Value™: €6.94 vs. price of €5.10 (26.5% below fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the FRA:JSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Other Exchanges SOLTF:USA4565:Japan
Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).
72GF Score

Get the complete analysis for FRA:JSS

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.10
Price
€6.94
GF Value